Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Infant, Premature, Diseases D007235 7 associated lipids
Infertility, Male D007248 11 associated lipids
Inflammation D007249 119 associated lipids
Intestinal Obstruction D007415 6 associated lipids
Ischemia D007511 18 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Klebsiella Infections D007710 7 associated lipids
Leukemia D007938 74 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Leukopenia D007970 9 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lupus Nephritis D008181 8 associated lipids
Lymphoma D008223 18 associated lipids
Malabsorption Syndromes D008286 16 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Medulloblastoma D008527 22 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Chen JJ and Liew CC Phosphorylation of an acid-soluble nuclear protein in response to catecholamine in cultured rat cardiocytes. 1993 Biochem. Biophys. Res. Commun. pmid:8439325
Muguruma K et al. Platelet-activating factor (PAF) in male reproductive organs of guinea pigs and rats: effect of androgen on PAF in seminal vesicles. 1993 Biol. Reprod. pmid:8439628
Garcia C et al. Biosynthesis of platelet-activating factor (PAF) induced by chemotactic peptide is modulated at the lyso-PAF:acetyl-CoA acetyltransferase level by calcium transient and phosphatidic acid. 1993 J. Biol. Chem. pmid:8440692
Noris M et al. Urinary excretion of platelet activating factor in patients with immune-mediated glomerulonephritis. 1993 Kidney Int. pmid:8441238
Wucherpfennig AL et al. Platelet activating factor increases intracellular calcium in isolated osteoclasts but does not modify bone resorption. 1993 Bone pmid:8442997
Tanaka T et al. Formation of platelet-activating factor-like phospholipids by Fe2+/ascorbate/EDTA-induced lipid peroxidation. 1993 Biochim. Biophys. Acta pmid:8443246
Tsuruta S et al. Effects of adenosine and its analogues on actin polymerization in human polymorphonuclear leucocytes. 1993 Clin. Exp. Pharmacol. Physiol. pmid:8443979
Huang YC et al. Protection against platelet-activating factor-induced injury by interferon inducer in perfused rabbit lung. 1993 J. Appl. Physiol. pmid:8444700
Mózes T et al. Protective effect of diclofenac sodium against endotoxic shock in anaesthetized pigs. 1993 Prostaglandins Leukot. Essent. Fatty Acids pmid:8446657
Wang F et al. A new protein kinase C, nPKC eta', and nPKC theta are expressed in human platelets: involvement of nPKC eta' and nPKC theta in signal transduction stimulated by PAF. 1993 Biochem. Biophys. Res. Commun. pmid:8447826
Filep JG et al. Nitric oxide modulates vascular permeability in the rat coronary circulation. 1993 Br. J. Pharmacol. pmid:8448583
Matthews JS and Jones RL Potentiation of aggregation and inhibition of adenylate cyclase in human platelets by prostaglandin E analogues. 1993 Br. J. Pharmacol. pmid:8448586
Arreto CD et al. Pharmacological differentiation by pertussis toxin of the in vivo acute responses to fMLP and PAF in guinea-pig lungs. 1993 Br. J. Pharmacol. pmid:8448592
Hirata Y et al. Roles of platelet-activating factor, thromboxane A2, ADP and thrombin in thrombogenesis in the guinea pig. 1993 Eur. J. Pharmacol. pmid:8449234
Hirashima Y et al. Platelet-activating factor and cerebral vasospasm following subarachnoid hemorrhage. 1993 J. Neurosurg. pmid:8450333
Mounier C et al. Competitive inhibition of phospholipase A2 activity by the platelet-activating factor antagonist Ro 19-3704 and evidence for a novel suppressive effect on platelet activation. 1993 J. Pharmacol. Exp. Ther. pmid:8450479
Green PG et al. Neurogenic and non-neurogenic mechanisms of plasma extravasation in the rat. 1993 Neuroscience pmid:8450970
Minami T et al. Regional blood flow volume in the eustachian tube. 1993 Acta Otolaryngol Suppl pmid:8452027
Church DJ et al. Protein kinase C-mediated phospholipase A2 activation, platelet-activating factor generation and prostacyclin release in spontaneously beating rat cardiomyocytes. 1993 Biochem. J. pmid:8452537
Pretolani M and Vargaftig BB From lung hypersensitivity to bronchial hyperreactivity. What can we learn from studies on animal models? 1993 Biochem. Pharmacol. pmid:8452553
Newman GE et al. Utilization by human amniocytes for prostaglandin synthesis of [1-14C]arachidonate derived from 2-[1-14C]arachidonylphosphatidylcholine associated with human fetal pulmonary surfactant. 1993 Biochim. Biophys. Acta pmid:8452866
Matsuda Y et al. Role of sympathetic nervous system in hypotension induced by platelet-activating factor in anesthetized dogs. 1993 Circ. Shock pmid:8453742
Damas J et al. Platelet-activating factor and the vascular effects of zymosan in rats. 1993 Eur. J. Pharmacol. pmid:8453979
Hatmi M et al. Carrageenan-induced activation of human platelets is dependent on the phospholipase C pathway. 1993 Br. J. Haematol. pmid:8457475
Lachapelle MH et al. Effect of lysoplatelet-activating factor on human sperm fertilizing ability. 1993 Fertil. Steril. pmid:8458509
Naraba H et al. Enhanced production of platelet-activating factor in stimulated rat leukocytes caused by the blockade of lysophospholipid acylation. 1993 Jpn. J. Pharmacol. pmid:8459648
Kosugi T et al. Inhalation of platelet-activating factor increases respiratory resistance in rats: determination by means of an astograph under nonanesthetized conditions. 1993 Laryngoscope pmid:8459752
Kertscher HP et al. [PAF-antagonists with a phospholipid structure. 5. Propanediol phospholipids with various substituted pyridinium and quinuclidinium head groups and variations of the phosphorus-nitrogen distance;synthesis, characterization and structure activity relationship]. 1993 Pharmazie pmid:8460172
Olson NC et al. Pertussis toxin attenuates platelet-activating factor-induced pulmonary hemodynamic alterations in pigs. 1993 Am. J. Physiol. pmid:8460710
Wieraszko A et al. Long-term potentiation in the hippocampus induced by platelet-activating factor. 1993 Neuron pmid:8461142
Venable ME et al. Enzymatic studies of lyso platelet-activating factor acylation in human neutrophils and changes upon stimulation. 1993 J. Biol. Chem. pmid:8463317
Battye KM et al. Potential synergism between platelet-activating factor and alpha 1-recombinant interferon in promoting luteal maintenance in cyclic ewes. 1993 J. Reprod. Fertil. pmid:8464013
Nagai H et al. Priming with murine recombinant interleukin-5 resulted in the augmentation of PAF-induced airway hyperresponsiveness to histamine in guinea pigs. 1993 Life Sci. pmid:8464339
Korth R et al. Human platelets release a paf-acether: acetylhydrolase similar to that in plasma. 1993 Lipids pmid:8464350
Ono S et al. Clinical and experimental studies on the role of platelet-activating factor (PAF) in the pathogenesis of septic DIC. 1993 Surg. Today pmid:8467174
McCafferty DM et al. Inhibition of platelet-activating factor-induced leukocyte adhesion in vivo by a leumedin. 1993 Eur. J. Pharmacol. pmid:8467855
Wong CW et al. Comparative effects of tetrandrine and berbamine on guineapig airway microvascular leakage induced by platelet-activating factor and other allergic mediators. 1993 Int. J. Immunopharmacol. pmid:8468119
Shikano M et al. Effect of docosahexaenoic acid on the generation of platelet-activating factor by eosinophilic leukemia cells, Eol-1. 1993 J. Immunol. pmid:8468486
Tetta C et al. Role of platelet activating factor in hemodialysis. 1993 Kidney Int. Suppl. pmid:8468919
Fukuoka T et al. Platelet activating factor mediates systemic circulatory collapse after temporary hepatic inflow occlusion. 1993 Transplant. Proc. pmid:8470175
Sandberg-Gertzén H An open trial of Cedemin, a Gingko biloba extract with PAF-antagonistic effects for ulcerative colitis. 1993 Am. J. Gastroenterol. pmid:8470656
Taylor ML et al. The differential effect of aspirin on human platelet activation in aspirin-sensitive asthmatics and normal subjects. 1993 Br J Clin Pharmacol pmid:8471399
Kroegel C and Matthys H Platelet-activating factor-induced human eosinophil activation. Generation and release of cyclo-oxygenase metabolites in human blood eosinophils from asthmatics. 1993 Immunology pmid:8473016
Juncos LA et al. Vasodilator and constrictor actions of platelet-activating factor in the isolated microperfused afferent arteriole of the rabbit kidney. Role of endothelium-derived relaxing factor/nitric oxide and cyclooxygenase products. 1993 J. Clin. Invest. pmid:8473488
Inui K [Participation of platelet activating factor in the pulmonary injury during cardiopulmonary bypass]. 1993 Nihon Kyobu Geka Gakkai Zasshi pmid:8473789
Minhas BS Platelet-activating factor treatment of human spermatozoa enhances fertilization potential. 1993 Am. J. Obstet. Gynecol. pmid:8475981
Björck T and Dahlén SE Leukotrienes and histamine mediate IgE-dependent contractions of human bronchi: pharmacological evidence obtained with tissues from asthmatic and non-asthmatic subjects. 1993 Pulm Pharmacol pmid:8477156
Makristathis A et al. Bacteria induce release of platelet-activating factor (PAF) from polymorphonuclear neutrophil granulocytes: possible role for PAF in pathogenesis of experimentally induced bacterial pneumonia. 1993 Infect. Immun. pmid:8478087
Walker TS and Mellott GE Rickettsial stimulation of endothelial platelet-activating factor synthesis. 1993 Infect. Immun. pmid:8478089
Lamouri A et al. Design and modeling of new platelet-activating factor antagonists. 1. Synthesis and biological activity of 1,4-bis(3',4',5'-trimethoxybenzoyl)-2-[[(substituted carbonyl and carbamoyl)oxy]methyl]piperazines. 1993 J. Med. Chem. pmid:8478911
Ranaut K and Singh M BN-50739: a PAF antagonist and limitation of myocardial infarct size. 1993 Jan-Feb Methods Find Exp Clin Pharmacol pmid:8479250
Murphy G Report of the 14th meeting of the British Inflammation Research Association. Topic: cellular and molecular aspects of inflammatory bowel disease. 1993 Agents Actions pmid:8480529
Hebra A et al. Systemic and mesenteric vascular effects of platelet-activating factor and cocaine. In vivo effects on a neonatal swine model. 1993 Am Surg pmid:8480932
Koenderman L et al. Granulocyte-macrophage colony-stimulating factor induces sequential activation and deactivation of binding via a low-affinity IgG Fc receptor, hFc gamma RII, on human eosinophils. 1993 Blood pmid:8481520
Kroegel C et al. Ultrastructural characterization of platelet-activating factor-stimulated human eosinophils from patients with asthma. 1993 Clin. Sci. pmid:8482044
Kiyohara T et al. Effect of endothelin 1 on ion transport in isolated rat colon. 1993 Gastroenterology pmid:8482447
Sakamoto T et al. Effect of inhaled lyso-platelet-activating factor on airway microvascular leakage in the guinea pig. 1993 J. Appl. Physiol. pmid:8482649
van der Bruggen T et al. Cytokine priming of the respiratory burst in human eosinophils is Ca2+ independent and accompanied by induction of tyrosine kinase activity. 1993 J. Leukoc. Biol. pmid:8482914
Yamanaka S et al. 11-Dehydro thromboxane B2: a reliable parameter of thromboxane A2 production in dogs. 1993 Prostaglandins pmid:8484010
Lohman IC and Halonen M The effects of combined histamine and platelet-activating factor antagonism on systemic anaphylaxis induced by immunoglobulin E in the rabbit. 1993 Am. Rev. Respir. Dis. pmid:8484635
Catalán RE et al. Platelet-activating factor stimulates protein kinase C translocation in cerebral microvessels. 1993 Biochem. Biophys. Res. Commun. pmid:8484756
Barthelson RA Quantitation of IL-4 expression in small numbers of cells from mice. 1993 J. Immunol. Methods pmid:8486929
Steinke B et al. [Biological standardization of Ginkgo extracts]. 1993 Planta Med. pmid:8488195
Lekka M et al. Isolation of a phospholipid inhibitor of platelet activating factor-induced activity from perfused rat liver: identification as phosphatidylglycerol. 1993 Arch. Biochem. Biophys. pmid:8489242
Sablina MA et al. [Synthesis of platelet activation factor analogs]. 1993 Bioorg. Khim. pmid:8489534
Cipolle MD et al. Secondary organ dysfunction. From clinical perspectives to molecular mediators. 1993 Crit Care Clin pmid:8490763
Kawada I and Takahashi K [A new method for the isolation of peripheral blood eosinophils using flow cytometry (FCM)]. 1993 Nippon Rinsho pmid:8492447
Iwahisa Y et al. [Advance in eosinophil chemotaxis assay method--automatic count of migrated cells by the image analyzing system in the Boyden method]. 1993 Nippon Rinsho pmid:8492448
Fukuda T [The eosinophil and bronchial asthma]. 1993 Nippon Rinsho pmid:8492453
Wagner G et al. [Synthesis of N-(2-carboxy-thieno(2,3-b)pyridin-3-yl)-formamidines corresponding alkyl esters with antianaphylactic activity]. 1993 Pharmazie pmid:8493283
Alabaster VA and Moore BA New perspectives on basic mechanisms in lung disease. 3. Drug intervention in asthma: present and future. 1993 Thorax pmid:8493636
Zhou W et al. Platelet-activating factor: a mediator of pancreatic inflammation during cerulein hyperstimulation. 1993 Am. J. Pathol. pmid:8494049
Nathan N and Denizot Y Tumor necrosis factor and platelet-activating factor during cardiopulmonary bypass. 1993 Ann. Thorac. Surg. pmid:8494455
Pons F et al. Role of platelet-activating factor (PAF) in platelet accumulation in rabbit skin: effect of the novel long-acting PAF antagonist, UK-74,505. 1993 Br. J. Pharmacol. pmid:8495241
Jarvi K et al. Effect of platelet-activating factor, lyso-platelet-activating factor, and lysophosphatidylcholine on sperm motion: importance of albumin for motility stimulation. 1993 Fertil. Steril. pmid:8495776
Trova MP et al. Analogues of platelet activating factor. 8. Antagonists of PAF containing an aromatic ring linked to a pyridinium ring. 1993 J. Med. Chem. pmid:8496938
Miura S et al. Attenuation of endotoxin-induced intestinal microcirculatory damage by eicosapentanoic acid. 1993 Am. J. Physiol. pmid:8498509
Shibamoto T et al. PAF increases capillary pressure but not vascular permeability in isolated blood-perfused canine lungs. 1993 Am. J. Physiol. pmid:8498559
Wilson DV and Stick JA Effect of a specific platelet-activating factor antagonist on cardiovascular and peripheral cellular responses to colonic ischemia and reperfusion in anesthetized ponies. 1993 Am. J. Vet. Res. pmid:8498751
Roudebush WE et al. Enhanced embryo development of rabbit oocytes fertilized in vitro with platelet activating factor (PAF)-treated spermatozoa. 1993 J. Assist. Reprod. Genet. pmid:8499686
Chu M et al. A novel class of platelet activating factor antagonists from Phoma sp. 1993 J. Antibiot. pmid:8500998
Inoue H et al. Study on the metabolism of lyso-platelet activating factor (lyso-PAF) in human paranasal sinus mucosa. The cultured ciliated epithelium can convert lyso-PAF to PAF. 1993 Life Sci. pmid:8502110
Pfliegler G et al. Sodium fluoride induced activation of phospholipase C in intact human platelets does not depend on ADP, PAF or arachidonate products. 1993 Thromb. Res. pmid:8503122
Sun DX et al. Platelet activating factor production in bovine cerebral microvascular endothelial cells and its drug inhibition. 1993 Zhongguo Yao Li Xue Bao pmid:8503282
Baldi E et al. Stimulation of platelet-activating factor synthesis by progesterone and A23187 in human spermatozoa. 1993 Biochem. J. pmid:8503848
Ferraris L et al. Intestinal epithelial cells contribute to the enhanced generation of platelet activating factor in ulcerative colitis. 1993 Gut pmid:8504968
Davis TM et al. Platelet-activating factor and lipid metabolism in acute malaria. 1993 J. Infect. pmid:8505562
Sirén AL et al. Increased release of tumor necrosis factor-alpha into the cerebrospinal fluid and peripheral circulation of aged rats. 1993 Stroke pmid:8506560
Misawa M and Sugiyama Y An airway hyperresponsiveness model in rat allergic asthma. 1993 Arerugi pmid:8507151
Tsukioka K et al. [Increased plasma levels of platelet-activating factor (PAF) and low serum PAF acetylhydrolase (PAFAH) activity in adult patients with bronchial asthma]. 1993 Arerugi pmid:8507159
Ono I et al. Effects of a platelet activating factor antagonist on oedema formation following burns. 1993 Burns pmid:8507364
van den Bosch H et al. Ether lipid synthesis and its deficiency in peroxisomal disorders. 1993 Biochimie pmid:8507680
Warringa RA et al. Upregulation of formyl-peptide and interleukin-8-induced eosinophil chemotaxis in patients with allergic asthma. 1993 J. Allergy Clin. Immunol. pmid:8509580
Dell' Albani P et al. Platelet-activating factor and its methoxy-analogue ET-18-OCH3 stimulate immediate early gene expression in rat astroglial cultures. 1993 Neurochem. Int. pmid:8513284
Koyama N et al. Increased platelet activating factor in the tracheal aspirates from neonates with patent ductus arteriosus. 1993 Clin. Chim. Acta pmid:8513570
Rabinovici R et al. ARDS-like lung injury produced by endotoxin in platelet-activating factor-primed rats. 1993 J. Appl. Physiol. pmid:8514698
Nishiyama R et al. Platelet-activating factor in hepatic ischemia/reperfusion injury. The effects of a PAF antagonist combined with a prostaglandin I2 analogue. 1993 Transplantation pmid:8516812
Kawahara K et al. The effect of the platelet-activating factor inhibitor TCV-309 on reperfusion injury in a canine model of ischemic lung. 1993 Transplantation pmid:8516834
Amorim CZ et al. Involvement of platelet-activating factor in death following anaphylactic shock in boosted and in unboosted mice. 1993 Eur. J. Pharmacol. pmid:8519279
Okano S et al. Effect of platelet activating factor antagonist (TCV-309) on lung injury in dogs with experimentally endotoxin-induced shock. 1995 J. Vet. Med. Sci. pmid:8519912